Search bioRxiv⌕ Search

Biology subjects

Williams, L. G.

Publications and source records attributed to Williams, L. G..

2 recordsLinked to original sources

An arginase 2 promoter transgenic illuminates anti-inflammatory signalling in zebrafish

The innate immune response to inflammatory stimuli must be finely balanced to produce an appropriate pro-inflammatory response while allowing a subsequent return to homeostasis. In recent years, in vivo transgenic zebrafish models have shed light on the temporal regulation of the pro-inflammatory innate response to immune challenges. However, until now, there have been no zebrafish transgenic models of anti-inflammatory signalling. We compared existing expression data of arginase genes in zebrafish neutrophils and macrophages, strong candidates for an anti-inflammatory marker, and identified that arginase 2 is the most highly expressed Arginase in zebrafish immune cells. We developed an arginase 2 (arg2) bacterial artificial chromosome (BAC) transgenic line, TgBAC(arg2:eGFP)sh571, driving GFP expression under the control of the arg2 promoter. We show that, under resting conditions, arg2:GFP is expressed in ionocytes, matching the in situ hybridisation pattern. Upon immune challenge by injury, bacterial and fungal insults, arg2:GFP is predominantly expressed in neutrophils at early timepoints post-insult. Later in infections, arg2:GFP is expressed in cells associated with foci of infection (including neutrophils and macrophages), alongside liver expression. Our data indicate that arginase 2 is predominantly expressed in neutrophils after immune challenge and suggest that anti-inflammatory signals coincide with pro-inflammatory signals during early wound and infection responses.

immunology↗

Mouse model and human patient data suggest critical roles for Pten and p53 in suppressing POLE mutant tumor development

Mutations in the exonuclease domain of POLE are associated with tumors harboring very high mutation burdens. The mechanisms linking this significant mutation accumulation and tumor development remain poorly understood. Pole+/P286R;Trp53+/- mice showed accelerated cancer mortality compared to Pole+/P286R;Trp53+/+ mice. Cells from Pole+/P286R mice showed increased p53 activation, and subsequent loss of p53 permitted rapid growth, implicating canonical p53 loss of heterozygosity in POLE mutant tumor growth. Somewhat surprisingly, however, p53 status had no effect on tumor mutation burden or single base substitution signatures in POLE mutant tumors from mice or humans. Pten has important roles in maintaining genome stability. We find that PTEN mutations are highly enriched in human POLE mutant tumors, including many in POLE signature contexts. One such signature mutation, PTEN-F341V, was previously shown in a mouse model to specifically decrease nuclear Pten and lead to increased DNA damage. We found tumors in Pole+/P286R mice that spontaneously acquired PtenF341V mutations and were associated with significantly reduced nuclear Pten and elevated DNA damage. Taken together with recent published work, our results support the idea that POLE-mediated hypermutagenesis is necessary, but not entirely sufficient, for tumorigenesis. Disabling surveillance of nuclear DNA damage is a likely sufficient factor.

cancer biology↗